Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 145

1.

Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

Tsvetkova E, Sud S, Aucoin N, Biagi J, Burkes R, Samson B, Brule S, Cripps C, Colwell B, Falkson C, Dorreen M, Goel R, Halwani F, Marginean C, Maroun J, Michaud N, Tehfe M, Thirlwell M, Vickers M, Asmis T.

Curr Oncol. 2016 Aug;23(4):e435. doi: 10.3747/co.23.3283. Epub 2016 Aug 12.

2.

Tissue Factor Pathway Inhibitor Gene Polymorphism -33T → C Predicts Improved Disease-Free Survival in Colorectal Cancer.

Bazzarelli AK, Scheer AS, Tai LH, Seth R, de Souza CT, Petrcich W, Jonker DJ, Maroun JA, Carrier M, Auer RC.

Ann Surg Oncol. 2016 Jul;23(7):2274-80. doi: 10.1245/s10434-016-5169-4. Epub 2016 Mar 11.

PMID:
26968713
3.

Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.

Di Valentin T, Asmis T, Asselah J, Aubin F, Aucoin N, Berry S, Biagi J, Booth CM, Burkes R, Coburn N, Colwell B, Cripps C, Dawson LA, Dorreen M, Frechette D, Goel R, Gray S, Hammad N, Jonker D, Kavan P, Maroun J, Nanji S, Roberge D, Samson B, Seal M, Shabana W, Simunovic M, Snow S, Tehfe M, Thirlwell M, Tsvetkova E, Vickers M, Vuong T, Goodwin R.

Curr Oncol. 2016 Feb;23(1):52-5. doi: 10.3747/co.23.2897. Epub 2016 Feb 18.

4.

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.

Schmoll HJ, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Hoersch S, Rittweger K, Haller DG.

J Clin Oncol. 2015 Nov 10;33(32):3733-40. doi: 10.1200/JCO.2015.60.9107. Epub 2015 Aug 31.

PMID:
26324362
5.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

Tsvetkova E, Sud S, Aucoin N, Biagi J, Burkes R, Samson B, Brule S, Cripps C, Colwell B, Falkson C, Dorreen M, Goel R, Halwani F, Maroun J, Michaud N, Tehfe M, Thirlwell M, Vickers M, Asmis T.

Curr Oncol. 2015 Aug;22(4):e305-15. doi: 10.3747/co.22.2603. Erratum in: Curr Oncol. 2016 Aug;23(4):e435.

6.

Complete Genome of Bacillus megaterium Podophage Pascal.

Snowden JD, Vega Gonzalez AE, Maroun JW, Hernandez AC, Kuty Everett GF.

Genome Announc. 2015 Jan 29;3(1). pii: e01429-14. doi: 10.1128/genomeA.01429-14.

7.

Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.

Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, Mukhtar T, Pasieka J, Rayson D, Rowsell C, Sideris L, Wong R, Law C.

Ann Surg Oncol. 2015 Aug;22(8):2685-99. doi: 10.1245/s10434-014-4145-0. Epub 2014 Nov 4.

PMID:
25366583
8.

Different roles of the three loops forming the adhesive interface of nectin-4 in measles virus binding and cell entry, nectin-4 homodimerization, and heterodimerization with nectin-1.

Mateo M, Navaratnarajah CK, Willenbring RC, Maroun JW, Iankov I, Lopez M, Sinn PL, Cattaneo R.

J Virol. 2014 Dec;88(24):14161-71. doi: 10.1128/JVI.02379-14. Epub 2014 Oct 1.

9.

Role of fine-needle aspiration in the surgical management of pancreatic neuroendocrine tumors: utility and limitations in light of the new World Health Organization classification.

Moyana TN, Kendal WS, Chatterjee A, Jonker DJ, Maroun JA, Grimard L, Shabana W, Mimeault R, Hakim SW.

Arch Pathol Lab Med. 2014 Jul;138(7):896-902. doi: 10.5858/arpa.2013-0300-OA.

PMID:
24978915
10.

Complete Genome of Bacillus thuringiensis Myophage Spock.

Maroun JW, Whitcher KJ, Chamakura KR, Kuty Everett GF.

Genome Announc. 2013 Dec 5;1(6). pii: e00863-13. doi: 10.1128/genomeA.00863-13.

11.

Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours.

Di Valentin T, Biagi J, Bourque S, Butt R, Champion P, Chaput V, Colwell B, Cripps C, Dorreen M, Edwards S, Falkson C, Frechette D, Gill S, Goel R, Grant D, Hammad N, Jeyakumar A, L'espérance M, Marginean C, Maroun J, Nantais M, Perrin N, Quinton C, Rother M, Samson B, Siddiqui J, Singh S, Snow S, St-Hilaire E, Tehfe M, Thirlwell M, Welch S, Williams L, Wright F, Goodwin R.

Curr Oncol. 2013 Oct;20(5):e455-64. doi: 10.3747/co.20.1638.

12.

Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers.

Di Valentin T, Alam Y, Ali Alsharm A, Arif S, Aubin F, Biagi J, Booth CM, Bourque S, Burkes R, Champion P, Colwell B, Cripps C, Dallaire M, Dorreen M, Finn N, Frechette D, Gallinger S, Gapski J, Giacomantonio C, Gill S, Goel R, Goodwin R, Grimard L, Grothey A, Hammad N, Hedley D, Jhaveri K, Jonker D, Ko Y, L'espérance M, Maroun J, Ostic H, Perrin N, Rother M, St-Hilaire E, Tehfe M, Thirlwell M, Welch S, Yarom N, Asmis T.

Curr Oncol. 2012 Jun;19(3):169-74. doi: 10.3747/co.19.931.

13.

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.

Vickers MM, Bar J, Gorn-Hondermann I, Yarom N, Daneshmand M, Hanson JE, Addison CL, Asmis TR, Jonker DJ, Maroun J, Lorimer IA, Goss GD, Dimitroulakos J.

Clin Exp Metastasis. 2012 Feb;29(2):123-32. doi: 10.1007/s10585-011-9435-3. Epub 2011 Nov 26.

PMID:
22120473
14.

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R.

Curr Oncol. 2011 Oct;18(5):228-40.

15.

Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer.

Gill S, Berry S, Biagi J, Butts C, Buyse M, Chen E, Jonker D, Mărginean C, Samson B, Stewart J, Thirlwell M, Wong R, Maroun JA.

Curr Oncol. 2011 Oct;18 Suppl 2:S5-S10.

16.
17.

Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.

Oza AM, Castonguay V, Tsoref D, Diaz-Padilla I, Karakasis K, Mackay H, Welch S, Weberpals J, Hoskins P, Plante M, Provencher D, Tonkin K, Covens A, Ghatage P, Gregoire J, Hirte H, Miller D, Rosen B, Maroun J, Buyse M, Coens C, Brady MF, Stuart GC.

Curr Oncol. 2011 Oct;18 Suppl 2:S20-7.

18.

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.

Hotte SJ, Bjarnason GA, Heng DY, Jewett MA, Kapoor A, Kollmannsberger C, Maroun J, Mayhew LA, North S, Reaume MN, Ruether JD, Soulieres D, Venner PM, Winquist EW, Wood L, Yong JH, Saad F.

Curr Oncol. 2011 Oct;18 Suppl 2:S11-9.

19.

Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.

Jonker DJ, Spithoff K, Maroun J; Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.

Clin Oncol (R Coll Radiol). 2011 Jun;23(5):314-22. doi: 10.1016/j.clon.2011.02.010. Epub 2011 Mar 11.

PMID:
21397476
20.

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K, Schmoll HJ.

J Clin Oncol. 2011 Apr 10;29(11):1465-71. doi: 10.1200/JCO.2010.33.6297. Epub 2011 Mar 7.

PMID:
21383294

Supplemental Content

Loading ...
Support Center